Equip

Equip offers modern, family-based eating disorder treatment delivered directly at home, aiming for lasting recovery. Founded in 2019, the company leverages expertise from both industry professionals and individuals with lived experience to provide a more accessible and affordable alternative to traditional treatment models. Equip's core offering is a dedicated five-person care team for each patient, comprising a therapist, dietician, physician, and peer and family mentor, all working collaboratively to support the patient's journey. This integrated approach addresses the obstacles families often face in seeking and maintaining effective treatment.

The company operates with a significant scale, employing between 500-1,000 individuals across its operations. This robust team structure is central to Equip's mission of providing comprehensive support. The virtual nature of their services ensures that families receive expert guidance without the disruption of in-person facility stays, making recovery more sustainable within their own environment. For insights into the individuals driving this mission, one can explore Meet Equip's team.

Equip has demonstrated substantial financial growth, reporting a revenue of $115.2M. The company has also secured significant funding, including a Series B round of $58 million in February 2022, underscoring investor confidence in its innovative approach. This financial backing supports its expansion and continued development of its virtual care platform. Further details on its financial performance and investment history are available via Explore financial highlights. Equip competes in the healthcare and hospitals & clinics sector, focusing on specialized treatment for eating disorders.